An Outpatient Treatment of comparative study on the efficacy and side effects of oxytocin + misoprostol with methyl ergonovin (metergin) + misoprostol and only misoprostol in the expulsion of first trimester intrauterine fetal dead

Not Applicable

• Conditions: Disposal of pregnancy products After spontaneous abortion.; Incomplete spontaneous abortion without complication; O03.4

• Registration Number: IRCT20150407021653N19
• Lead Sponsor: Jahrom University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Patients who tend to undergo outpatient treatment for the excretion of pregnancy products.
The gestational age should be under 14 weeks.
Do not have a history of high-risk diseases (diabetes and blood pressure and blood problems and cardiovascular diseases, etc.).

Exclusion Criteria

If there are certain illnesses, fever and blood pressure will be excluded from the study.
patients who do not tolerate drug therapy or will be tired of the treatment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Success in the pregnancy products excretion. Timepoint: During the 9 days after abortion. Method of measurement: Ultrasonography.;The remaining tissue size. Timepoint: During the 9 days after abortion. Method of measurement: Ultrasonography.

Secondary Outcome Measures

Name	Time	Method
Determine the mean time for disposal of pregnancy products after spontaneous abortion. Timepoint: After spontaneous abortion. Method of measurement: observation.